MiRNA-based therapy for Psoriasis: MiRNA-520c inhibits psoriasiform skin inflammation via down regulation of its target gene, 05/October/2014, 07.40 am

Expose yourself to optimal Sunlight to live longer: Nitric oxide increases male life span via down regulation of its target gene, 05/October/2014, 07.00 am
October 5, 2014
MiRNA-based therapy for Chronic Myelogenous Leukemia (CML): MiRNA-142 eradicates CML leukemia stem cells via activation of p53, 05/October/2014, 08.47 am
October 5, 2014
Show all

A recent study from the Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts; Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA; and Institute for Biomedical Research, University College London, London, UK shows that “Nociceptive sensory neurons drive interleukin-23-mediated psoriasiform skin inflammation.” This study was published in the Apr 23  2014 Nature by Prof Ulrich H. von AndrianLorena Riol-Blanco, and others.

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMDreports that: MiRNA-based therapy for Psoriasis: MiRNA-520c inhibits psoriasiform skin inflammation via down regulation of its target geneThis study suggests that MiRNA-520c, by decreasing the expression of its target gene, it may alleviate the interleukin-23-mediated psoriasiform skin inflammation. Together, this study suggests that pharmacological formulations encompassing MiRNA-520c or its activators” may be used to alleviate psoriasiform skin inflammation.

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, L., MiRNA-based therapy for Psoriasis: MiRNA-520c inhibits psoriasiform skin inflammation via down regulation of its target gene, 05/October/2014, 07.40 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Comments are closed.